Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
7.00
-0.26 (-3.58%)
At close: Mar 28, 2025, 4:00 PM
6.94
-0.06 (-0.86%)
After-hours: Mar 28, 2025, 7:59 PM EDT
Novavax Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Novavax stock have an average target of 17.83, with a low estimate of 9.00 and a high estimate of 26. The average target predicts an increase of 154.71% from the current stock price of 7.00.
Analyst Consensus: Buy
* Price targets were last updated on Dec 10, 2024.
Analyst Ratings
The average analyst rating for Novavax stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +171.43% | Dec 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +171.43% | Nov 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +171.43% | Nov 12, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $31 → $25 | Strong Buy | Maintains | $31 → $25 | +257.14% | Oct 16, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $23 → $26 | Strong Buy | Reiterates | $23 → $26 | +271.43% | Oct 10, 2024 |
Financial Forecast
Revenue This Year
492.79M
from 682.16M
Decreased by -27.76%
Revenue Next Year
566.80M
from 492.79M
Increased by 15.02%
EPS This Year
0.55
from -1.23
EPS Next Year
1.43
from 0.55
Increased by 160.49%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.2B | 933.0M | 482.6M | ||
| Avg | 492.8M | 566.8M | 310.9M | ||
| Low | 223.4M | 314.2M | 161.6M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 69.5% | 89.3% | -14.9% | ||
| Avg | -27.8% | 15.0% | -45.1% | ||
| Low | -67.2% | -36.2% | -71.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.47 | 2.28 | 1.77 | ||
| Avg | 0.55 | 1.43 | 1.58 | ||
| Low | -1.62 | 0.19 | 1.38 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 313.7% | 23.7% | ||
| Avg | - | 160.5% | 10.2% | ||
| Low | - | -66.2% | -3.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.